Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Osteosarcoma 1Intestinal Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Irinotecan 3pembrolizumab 2Oxaliplatin 2Leucovorin 2Fluorouracil 2trifluridine tipiracil drug combination 1pralsetinib 1napabucasin 1alectinib 1S-1 plus cisplatin 1Levoleucovorin 1KRN-330 1Indocyanine Green 1Imatinib Mesylate 1Fluorescein 1Docetaxel 1Cyclophosphamide 1Calcium Dobesilate 1Bupivacaine 1Bevacizumab 1Ascorbic Acid 15,10-methylenetetrahydrofolic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gastrointestinal Diseases × 5,10-methylenetetrahydrofolic acid × Clear all
NCT01681472 2020-09-25

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

Isofol Medical AB

Phase 1/2 Completed
32 enrolled 52 charts
Gastrointestinal

Colonic Neoplasms, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡